|
|
 |
|
Viewing report
|
|
|
|
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice
Datamonitor, March 2002
Over the last twelve months, the Alzheimer''s disease market has particularly eventful. The most exciting events have been the recent EU approval of Lundbeck''s memantine for moderate to severe Alzheimer''s disease and the US government''s decision to provide treatments to patients on Medicare, both of which will see a dramatic rise in the dollar market value. However, with the recent withdrawal of Elan''s hyped 'AD vaccine' from Phase II trials due to safety concerns, and the lack of accurate diagnostic technologies, the market still suffers from huge unmet needs. Moreover, the four drugs available to treat the disease provide only minimal symptomatic relief, and cannot modify the course of this debilitating brain disorder. Treatment Algorithms 2002: Alzheimer''s Disease is based upon extensive physician and opinion leader interviews that encompasses details on presentation, diagnosis and evaluation of Alzheimer''s disease across the seven major pharmaceutical markets. It provides insight and analysis into treatment patterns and provides physician scoring of Alzheimer''s disease drugs based on criteria such as safety, efficacy and cost.
Customers who bought this item also bought
Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite
Treatment Algorithms 2002: Venous Thromboembolism Acute Therapy
Treatment Algorithm 2001: Diabetes
Treatment Algorithms 2000: Rheumatoid Arthritis - Defining Changing Treatment Trends
Treatment Algorithms 2002: Hepatitis B and C
Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride
Treatment Algorithms 2001: Allergic Rhinitis - Unlocking the Real Patient Potential
Treatment Algorithms 2001: Stroke - Time is Brain
Stakeholder Insight: Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share as Novel Biologics Wait in the Wings
Market Dynamics 2001: Alzheimer''s Disease - An expanding market driven by Aricept
Br Malls Participacoes Sa
Br. Holdings Corporation
|
|
|
|
